Nassar George M
Nephrology, Dialysis, and Transplantation Associates, Department of Internal Medicine, Weill Cornell University at the Methodist Hospital, Houston, TX, USA.
Semin Dial. 2010 Mar-Apr;23(2):229-32. doi: 10.1111/j.1525-139X.2010.00713.x.
The Hemodialysis Reliable Outflow (HeRO) Vascular Access Device is a novel long-term subcutaneous dialysis graft, ideally suited for catheter-dependent patients and patients dialyzing with failing fistulas or grafts due to venous outflow stenosis. This case presentation depicts the clinical course of the first patient to enter a Food and Drug Administration approved clinical trial and receive the HeRO device. The course of this patient over 56 months of follow-up provides the longest experience with the HeRO device to-date. In this patient, the HeRO device provided long-term dialysis access patency in conjunction with adequate dialysis and a low intervention rate.
血液透析可靠流出道（HeRO）血管通路装置是一种新型的长期皮下透析移植物，非常适合依赖导管的患者以及因静脉流出道狭窄而使用功能衰竭的动静脉内瘘或移植物进行透析的患者。本病例报告描述了首例进入美国食品药品监督管理局批准的临床试验并接受HeRO装置的患者的临床过程。该患者56个月的随访过程提供了迄今为止使用HeRO装置最长时间的经验。在该患者中，HeRO装置结合充分的透析和低干预率，提供了长期的透析通路通畅性。
